Can this subcontract be signed electronically?

Yes. Electronic signatures are legally valid under the ESIGN Act (15 U.S.C. ch. 96, 2000) and UETA where adopted. Confirm contract content is not within ESIGN exceptions and ensure required FDA or agency rules (for electronic records) such as 21 CFR Part 11 are met.

When is a BAA required?

A Business Associate Agreement (BAA) is required whenever the subcontractor creates, receives, maintains, or transmits protected health information on behalf of the covered entity. Include BAA language in the subcontract and ensure technical safeguards meet HIPAA requirements.

Do FDA rules require digital signatures?

FDA regulations may require controls for electronic records and signatures under 21 CFR Part 11. For regulated submissions or records subject to Part 11, use compliant systems, maintain audit trails, and follow identity-proofing and record retention rules.

What if names mismatch on signatures?

Mismatched legal names between identification documents and signature blocks can delay verification, trigger backup withholding for tax matters, or create enforceability disputes. Update names prior to signing or include evidence of authorized signatory authority to reduce challenges.

Are witnesses or notaries required?

Not typically required for private subcontracts, but state law or prime contract flow-downs may demand notarization or witnesses. Verify applicable state notary rules and prime contract clauses; use RON where permitted to notarize remotely and capture audio-video proof.

How long must records be kept?

Retention depends on federal and contract requirements: keep financial records at least three years (IRC §6501), HIPAA-related records six years (45 CFR §164.530(j)), and retain contract records per clause or up to seven years post-termination where specified.

Electronic Signature
Templates
Healthcare
Healthcare FDA Subcontract

Healthcare FDA Subcontract

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE FDA SUBCONTRACT

Parties and Effective Date

This Subcontract is entered into by and between Contractor: and Subcontractor: (each a Party and collectively the Parties) effective as of .

Contractor Registered Address Contractor Primary Contact Subcontractor Registered Address Subcontractor Primary Contact

Recitals

WHEREAS, Contractor holds the prime contract or regulatory obligation (Prime Contract No.: ) under applicable Food and Drug Administration (FDA) requirements that involves activities regulated by the FDA; and

WHEREAS, Contractor desires to engage Subcontractor to perform certain services subject to FDA regulation on the terms and conditions set forth herein.

Scope of Work

Description of Services Key Deliverables and Schedule

Estimated final completion date: .

Compensation and Invoicing

Contractor shall pay Subcontractor for performance per the rates and amounts set forth below. Maximum aggregate subcontract value: $.

Payment Terms (description)

Invoices shall reference the Prime Contract number and be submitted to Contractor at the address for notices. Payment shall be made within days of receipt of a properly documented invoice.

FDA Regulatory and Quality Obligations

Subcontractor shall perform all work in compliance with all applicable FDA statutes, regulations, guidances and current Good Manufacturing/Clinical/Laboratory Practices (GMP/GCP/GLP) as applicable. Subcontractor shall maintain written procedures and records demonstrating compliance and shall permit Contractor and regulatory authorities reasonable access to facilities, personnel, and records for audit and inspection.

Subcontractor shall notify Contractor in writing within of any adverse event, product complaint, deviation, or event that may be reportable to the FDA or affect product safety, efficacy, or regulatory compliance.

Records Retention and Audit Rights

Subcontractor shall retain all records and data generated in performance of this Subcontract for a minimum of or for such longer period as required by applicable law or the Prime Contract. Contractor and regulatory authorities shall have the right to audit records upon reasonable notice.

Confidentiality and Protected Health Information

Subcontractor shall maintain the confidentiality of Contractor materials, proprietary information, and any Protected Health Information (PHI) received in the performance of this Subcontract. Subcontractor warrants that it will implement and maintain administrative, physical and technical safeguards required by applicable privacy laws.

Will Subcontractor create, receive, maintain, or transmit PHI on behalf of Contractor? Yes No

If yes, the Parties shall execute additional data protection and business associate terms sufficient to satisfy applicable law and to permit Contractor to comply with its obligations under such laws.

Intellectual Property

Unless otherwise agreed in writing, intellectual property and data arising solely from Subcontractor performance shall be owned as follows: Pre-existing intellectual property remains the property of the originating Party. New inventions or deliverables specifically created for Contractor under this Subcontract shall be owned by Contractor subject to any license expressly granted to Subcontractor.

Indemnification and Insurance

Subcontractor shall indemnify and hold harmless Contractor, its officers, employees and agents from and against all third-party claims, losses or liabilities arising out of Subcontractor's negligence, willful misconduct, or breach of this Subcontract, including failure to comply with FDA requirements.

Subcontractor shall maintain insurance in commercially reasonable amounts, including general liability and professional liability coverage with limits of not less than $ per occurrence, and shall provide certificates of insurance upon request.

Term and Termination

This Subcontract shall commence on the Effective Date and continue until completion of the Scope of Work unless earlier terminated. Contractor may terminate for convenience upon days' written notice. Either Party may terminate for material breach if the breach is not cured within days after written notice.

Flow-down and Prime Contract Obligations

Subcontractor agrees to incorporate and comply with all flow-down clauses required by the Prime Contract and shall not take any action that would violate Contractor's obligations to Prime Contracting authorities, including but not limited to compliance with applicable FDA regulations.

Notices

Notice Address for Contractor Notice Address for Subcontractor

Governing Law and Dispute Resolution

This Subcontract shall be governed by the laws of the State of without regard to conflict of law principles. The Parties shall attempt to resolve disputes in good faith; if unresolved, disputes shall be resolved by binding arbitration in the designated forum unless the Parties agree otherwise in writing.

Representations, Warranties and Certifications

Each Party represents and warrants that it has the power and authority to enter into this Subcontract and that performance will comply with applicable laws and regulations. Subcontractor certifies that personnel performing work are properly qualified and that any data provided is accurate to the best of Subcontractor's knowledge.

Miscellaneous

This Subcontract constitutes the entire agreement between the Parties with respect to the subject matter hereof and supersedes all prior agreements. Amendments must be in writing and signed by authorized representatives of both Parties.

Contractor:

Subcontractor:

By:

Date:

What the Healthcare FDA Subcontract Is

The Healthcare FDA Subcontract is a written agreement used when a prime contractor assigns or delegates specific services, supply obligations, or research tasks related to FDA-regulated healthcare products to a subcontractor. It establishes scope of work, quality standards, regulatory responsibilities (including 21 CFR compliance where applicable), reporting and inspection rights, confidentiality obligations, and indemnification. These subcontracts clarify which party is responsible for FDA-required documentation, adverse event reporting, and recordkeeping, and they define deliverables, timelines, and dispute resolution terms tailored to FDA-controlled projects.

Why a Clear Healthcare FDA Subcontract Matters

Use a Healthcare FDA Subcontract to allocate regulatory duties, reduce compliance gaps, and document expectations between contracting parties. Properly drafted subcontracts help manage 21 CFR obligations, limit contractual ambiguity, and provide clear audit trails useful for FDA inspections and legal review.

Who Prepares and Signs These Subcontracts

Typical parties that prepare or sign Healthcare FDA Subcontracts include prime contractors, subcontractors, clinical vendors, and contract managers.

Prime contractor contract managers who retain ultimate regulatory responsibility and manage subcontract performance.
Subcontractor compliance leads responsible for meeting 21 CFR quality and reporting obligations under the subcontract.
Quality assurance, clinical operations, legal counsel, and regulatory affairs teams reviewing contract terms for FDA alignment.

Align roles early and document responsibilities to reduce inspection findings and contractual disputes during FDA review or audits.

Primary Elements to Include in the Subcontract

Core elements that should appear in a professional Healthcare FDA Subcontract to protect compliance, quality, and regulatory reporting obligations effectively.

Scope of Work

Define specific tasks, deliverables, acceptance criteria, timelines, milestones, and deliverable formats. Explicitly reference FDA-regulated materials or processes and include sampling, testing, and release responsibilities, including documentation requirements.

Regulatory Duties

Allocate which party completes FDA-required filings, adverse event reporting, device or drug complaint handling, and interactions with regulatory authorities. Specify timelines, responsible contacts, and escalation paths.

Quality Requirements

Include applicable quality system standards, inspections rights, change control procedures, deviation reporting, CAPA responsibilities, and required certificates such as COA or CAP certificates where relevant to FDA-regulated products.

Data & Records

Specify recordkeeping standards, electronic record formats, retention periods, access for audits, data ownership, and provisions for transferring or producing records during FDA inspection including timestamps and metadata.

Confidentiality

Define proprietary information classifications, permitted disclosures, handling of trade secrets, and required data protection measures to meet HIPAA when PHI is involved, including breach notification responsibilities.

Indemnity & Liability

Allocate indemnification for regulatory violations, product defects, or third-party claims; cap liability where permitted by law; specify insurance requirements and coordination for recalls and corrective actions.

Security and Compliance Essentials

HIPAA Status: BAA required for PHI

21 CFR Part 11: Controls for electronic records

Encryption: TLS 1.2/1.3 in transit

At-rest Encryption: AES-256 on stored files

Audit Trail: Timestamps, IP, action log

Access Controls: Role-based signer and admin permissions

Step-by-Step: From Drafting to Signed Agreement

Follow these steps to complete a Healthcare FDA Subcontract and maintain a compliant audit trail for electronic signatures and recordkeeping.

01

Prepare Document: Draft terms, scope, and regulatory obligations clearly.
02

Assign Roles: Name responsible contacts and escalation paths.
03

Review & Approve: Legal and QA review for 21 CFR alignment.
04

Sign & Store: Obtain signatures, retain records per retention policy.

Configuring an Online Signing Workflow

Configure an online signing workflow to capture required audits, authentication, and document routing specific to FDA-regulated subcontract workflows.

Field	Configuration
Signer Authentication	Email or SMS code; consider KBA for high-risk
Document Fields	Signatures, initials, dates, attachments allowed
Conditional Routing	Route by role, compliance flags, or approvals
Audit Trail Settings	Retain timestamps, IPs, and completion certificate

Typical Submission and Routing Flow

Typical routing and submission flow for Healthcare FDA Subcontracts, from upload through signature, verification, and archival.

Upload: Sender uploads final subcontract package.
Assign Fields: Place signature, date, and compliance fields.
Authenticate: Signer verifies identity via chosen method.
Archive: Store signed copy with audit certificate.

Platform and Integration Considerations

Platform considerations for distributing and electronically signing Healthcare FDA Subcontracts across teams and external partners.

Formats: PDF, Word DOCX accepted
Integrations: Connectors: NetSuite, Google Workspace, Salesforce
Authentication: Support email, SMS, KBA, and SSO

Deadlines, Notification Windows, and Retention Triggers

Key timelines and deadlines to track when negotiating and executing a Healthcare FDA Subcontract, including response times and retention triggers.

Effective Date Entry:

Use MM/DD/YYYY and confirm start of obligations.

Change Control Windows:

Record change approvals and dates per quality procedure.

Adverse Event Reporting:

Report timelines must meet FDA requirements and contract terms.

Audit Access Notice:

Provide reasonable notice and access windows for inspections.

Record Retention Trigger:

Retention begins at document creation or effective date.

Key Milestones Through the Subcontract Lifecycle

Sequence of major milestones from drafting through post-execution compliance and inspection readiness for the subcontract lifecycle.

01

Draft Agreement

Define scope, responsibilities, and quality criteria before review.

02

Internal Approvals

Legal, QA, and procurement sign off prior to external execution.

03

Execution & Signing

Complete signatures, capture authentication, and issue executed copies.

04

Post-Execution Review

Archive documents, update tracking, and prepare for audits.

How to Update or Amend the Subcontract

Procedures for revising, amending, and re-executing Healthcare FDA Subcontracts after initial execution while preserving audit trail.

01

Initiate Amendment:

Document change rationale and scope.

02

Obtain Approvals:

Collect signoffs from legal and QA.

03

Update Records:

Revise effective dates and version numbers.

04

Re-sign:

Execute signatures on updated pages only.

05

Distribute:

Send copy to all stakeholders and archive.

06

Audit Note:

Log change in audit trail with reason.

Common Mistakes to Avoid

Failing to assign regulatory tasks clearly can leave both parties exposed during FDA inspections, causing duplicate work and unclear responsibility for compliance actions.
Vague quality requirements or missing acceptance criteria lead to disputes over deliverables and delays in product release or study milestones.
Incorrect retention instructions or failure to include HIPAA provisions can produce compliance gaps and trigger costly remediation or penalties.
Using inconsistent naming, missing signature dates, or mismatched legal names can render the subcontract ambiguous or unusable in disputes.

Penalties and Contractual Risks

Contract Invalidity: Ambiguity may weaken enforceability

Regulatory Noncompliance: Violations risk FDA action

Monetary Fines: Potential civil penalties

Operational Delays: Production or study holds

Reputational Harm: Loss of trust with partners

Increased Liability: Broader indemnity exposure

Exporting and Packaging the Final Agreement

Practical document handling features for completed Healthcare FDA Subcontracts, including export formats, document packages, and supporting attachments for audits.

Export Formats

Provide signed copies in PDF/A and DOCX. Include embedded audit certificate to preserve signature metadata for inspections and system export logs for long-term storage and chain-of-custody details.

Combined Package

Bundle subcontract, BAA, insurance certificates, COI, and relevant SOP excerpts into a single package for review and inspection readiness and include an index and version history for each attachment.

Signed Audit

Attach completion certificate showing signer identity, timestamps, IP addresses, and authentication method to support FDA inquiries or audits and retain exportable logs for at least the required retention period.

Version Control

Ensure version numbering, effective dates, and amendment history are clearly labeled; require initials or signatures on amendments to avoid confusion and record approver names and timestamps in the audit log.

eSignature Pricing and Feature Snapshot for Subcontract Workflows

Pricing and feature comparison for eSignature vendors commonly used with Healthcare FDA Subcontracts; evaluate HIPAA, bulk send, and audit capabilities.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day trial	No	No	Yes, limited	Yes, limited
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

FAQs: Execution, Signing, and Compliance Questions

Answers to common questions about executing, signing, and enforcing Healthcare FDA Subcontracts, including eSignature and compliance considerations.

Need help? Contact support

Can this subcontract be signed electronically?
Yes. Electronic signatures are legally valid under the ESIGN Act (15 U.S.C. ch. 96, 2000) and UETA where adopted. Confirm contract content is not within ESIGN exceptions and ensure required FDA or agency rules (for electronic records) such as 21 CFR Part 11 are met.
When is a BAA required?
A Business Associate Agreement (BAA) is required whenever the subcontractor creates, receives, maintains, or transmits protected health information on behalf of the covered entity. Include BAA language in the subcontract and ensure technical safeguards meet HIPAA requirements.
Do FDA rules require digital signatures?
FDA regulations may require controls for electronic records and signatures under 21 CFR Part 11. For regulated submissions or records subject to Part 11, use compliant systems, maintain audit trails, and follow identity-proofing and record retention rules.
What if names mismatch on signatures?
Mismatched legal names between identification documents and signature blocks can delay verification, trigger backup withholding for tax matters, or create enforceability disputes. Update names prior to signing or include evidence of authorized signatory authority to reduce challenges.
Are witnesses or notaries required?
Not typically required for private subcontracts, but state law or prime contract flow-downs may demand notarization or witnesses. Verify applicable state notary rules and prime contract clauses; use RON where permitted to notarize remotely and capture audio-video proof.
How long must records be kept?
Retention depends on federal and contract requirements: keep financial records at least three years (IRC §6501), HIPAA-related records six years (45 CFR §164.530(j)), and retain contract records per clause or up to seven years post-termination where specified.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now